Hodgson, Darren R <br/><br/>
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.  [electronic resource] 

 -  British journal of cancer  11 2018 
 - 1401-1409 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/s41416-018-0274-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>BRCA1 Protein--genetics<br/>BRCA2 Protein--genetics<br/>Biomarkers, Tumor--metabolism<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Ovarian Neoplasms--drug therapy<br/>Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use